Prudential Financial Inc Orgenesis Inc. Transaction History

Prudential Financial Inc

  • $70 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$0.44 - $0.96 $3,520 - $7,680
-8,000 Reduced 42.11%
11,000 $5,000
Q3 2023

Nov 13, 2023
BUY
$0.41 - $1.4 $7,789 - $26,600
19,000 New
19,000 $11,000
Q1 2023

May 12, 2023
BUY
$1.18 - $2.59 $3,068 - $6,734
2,600 Added 10.42%
27,550 $32,000
Q4 2022

Feb 14, 2023
BUY
$1.18 - $2.24 $6,608 - $12,544
5,600 Added 28.94%
24,950 $0
Q3 2022

Nov 04, 2022
BUY
$1.38 - $2.38 $26,702 - $46,053
19,350 New
19,350 $27,000

Others Institutions Holding ORGS

# of Institutions
2
Shares Held
134K
Call Options Held
0
Put Options Held
0
View Full List

About Orgenesis Inc.

ORGS Quotes by TradingView
  • Ticker ORGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,545,800
  • Market Cap $28.1M
  • Description
  • Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...
More about ORGS
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email